Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Accumulated Expenses (2016 - 2025)

Qiagen's Accumulated Expenses history spans 17 years, with the latest figure at $439.5 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 8.01% to $439.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $439.5 million, a 8.01% increase, with the full-year FY2025 number at $439.5 million, up 8.01% from a year prior.
  • Accumulated Expenses hit $439.5 million in Q4 2025 for Qiagen, up from $406.9 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for QGEN hit a ceiling of $568.6 million in Q4 2021 and a floor of $406.9 million in Q4 2024.
  • Historically, Accumulated Expenses has averaged $461.7 million across 5 years, with a median of $439.5 million in 2025.
  • Biggest five-year swings in Accumulated Expenses: surged 38.19% in 2021 and later dropped 16.26% in 2023.
  • Tracing QGEN's Accumulated Expenses over 5 years: stood at $568.6 million in 2021, then fell by 14.49% to $486.2 million in 2022, then dropped by 16.26% to $407.2 million in 2023, then dropped by 0.07% to $406.9 million in 2024, then increased by 8.01% to $439.5 million in 2025.
  • Business Quant data shows Accumulated Expenses for QGEN at $439.5 million in Q4 2025, $406.9 million in Q4 2024, and $407.2 million in Q4 2023.